CAM
ZBH icon

Creekmur Asset Management’s Zimmer Biomet ZBH Stock Holding History

Creekmur Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-80
Closed -$9.74K – 917
2023
Q4 		$9.74K Buy
+80
New +$8.93K ﹤0.01% 530

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Creekmur Asset Management's ZBH Position: Q1 2024 in Review

Creekmur Asset Management sold out of Zimmer Biomet (ZBH) in Q1 2024, closing a stake of 80 shares — an estimated $9.74K sold.

Creekmur Asset Management first reported a position in ZBH in Q4 2023 and held it in 1 quarter. The position peaked at $9.74K in Q4 2023. 1,011 funds tracked by Wall St. Rank hold ZBH as of Q1 2024.

  • Creekmur Asset Management reported no remaining Zimmer Biomet position as of Q1 2024 after selling out during the quarter.
  • Creekmur Asset Management sold 80 Zimmer Biomet shares in Q1 2024, an estimated $9.74K.
  • Creekmur Asset Management first reported a position in Zimmer Biomet in Q4 2023 and held it in 1 quarter.
  • Creekmur Asset Management's Zimmer Biomet position peaked at $9.74K in Q4 2023.
  • 1,011 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2024.

Based on Creekmur Asset Management's 13F filing for Q1 2024, filed 16 May 2024.